恆指午後曾跌破26,100 惟蒙牛/藥明生物/創科及科技股彈逾2%-4.5%
投資者重新權衡疫苗研發露曙光及環球疫情激增與經濟反彈的可能時機,資金再次由舊經濟股轉投科技股,恆指昨天反覆回軟結束四連漲後,今早在三大科技股急彈推動高開0.7%報26,409,進一步升至26,460無以為繼,在金融及地產板塊顯著回吐拖累下,午後跌幅曾擴至155點,低見26,071,現造26,106,倒跌120點或0.5%,成交額1,323億元。
內地10月新增貸款回落至6,898億元人民幣創一年低兼不及市場預期7,500億人民幣。四大藍籌內銀全部回吐,尤其是工行(01398.HK)及中行(03988.HK)由近四個月及四個月高位回落,最低見4.71元及2.75元,現造4.76元及2.76元,回吐2.7%及2.1%;建行(00939.HK)曾由近四個月高位回吐2.7%至6.02元獲承接,現造6.11元,僅回吐1.3%。
匯控(00005.HK)今早高開進一步升至39.7元(受制7月初所造40元),掉頭低見38元,現造38元,倒跌2.5%,結束八連漲;旗下恆生(00011.HK)由逾四個高位回落,最低見129.2元,現造130.7元,回吐3.2%。此外,國壽(02628.HK)及友邦(01299.HK)分別吐逾1.5%及3.5%,低見17.74元及83.35元。不過,上季多賺52%勝預期獲野村升價462.9元的港交所(00388.HK)由高位兩連吐守穩百天線,今天股價曾重越50天及20天線(372.8元),最高見375元,現造370.6元,回升1.4%。
地產收租股除恆隆地產(00101.HK)窄幅逆穩外,全部回吐逾1.5%-4%,新地(00016.HK)、新世界(00017.HK)、中海外(00688.HK)及潤地(01109.HK)回吐壓力最大,股價依次跌2.8%-4.2%,分別低見103.9元、39.6元、20.85元及36.7元。此外,中移動(00941.HK)及聯通(00762.HK)回升受制牛熊線,今天股價吐逾3%及4%,分別低見51.15元及5.28元。
相反,阿里(09988.HK)、小米(01810.HK)及今天放榜騰訊(00700.HK)扭轉連日捱沽頹勢,股價隨美國科技股反彈逾2%-4.5%,分別高見258.6元、24元及586元。此外,舜宇(02382.HK)、蒙牛(02319.HK)、創科(00669.HK)及藥明生物(02269.HK)升近3%-4%,分別報149.3元/41.3元/101.3元/232.2元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
![](/hk/assets/image/code.84ab0b.png)
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.